The BRAAVE2020 study investigated the efficacy of switching Black Americans living with HIV to a B/F/TAF single-pill regimen.

A new study from Tulane University finds that historical race-based lending practices are still impacting health today, ...

A University of Minnesota Medical School research team has found that giving iron supplements to children living with human immunodeficiency virus (HIV) in sub-Saharan Africa could be an important ...

To say that efficacy trials of HIV vaccines and microbicides have, to date, been disappointing is something of an understatement. Several microbicides have been tested in phase 3 trials. At best ...

The HIV pandemic has brought this issue to the fore. We believe that research is essential and that to ignore it is to focus on the short-term problem at the expense of longer-term solutions.

All publications and presentations resulting from research projects for which you have received funding, services, or mentorship through the Texas D-CFAR must acknowledge CFAR. Texas Developmental ...

The UAB Center for AIDS Research (CFAR) is a vibrant, energetic center at the nexus of HIV research in Alabama. Since 1988, the center has been innovating and evolving itself alongside the HIV ...

A virologist at the University of Nebraska-Lincoln, Qingsheng Li, was awarded $3.5 million to advance his work on a vaccine ...

Research on HIV tests is only occasionally published in medical journals. Informally, laboratory professionals may have insights into which tests perform best. It is important to verify that any test ...

Gilead (GILD) announced the upcoming presentation of HIV research findings at the International Congress on Drug Therapy in HIV Infection, ...

How long are the window periods of different HIV tests? It is hard to say exactly how long the window period lasts, as there are variations between individuals and it is a difficult topic to research ...

The Division of Infectious Diseases and HIV Medicine is expanding our translational research program, and investigating cutting-edge technologies, vaccines, and therapeutic treatments for the ...